abstract |
The present invention relates to a combination comprising tasquinimod, or a pharmaceutically acceptable salt thereof, and a PD-1 and/or PD-L1 inhibitor for use as a medicament. This invention also relates to pharmaceutical compositions comprising taquinomod, or a pharmaceutically acceptable salt thereof, and a PD-1 and/or PD-L1 inhibitor. |